complete remission rates have improved from about 40% to a range of 80-90%, and survival rates to 40-50% over the last 10 years
improved treatment success is believed to be the result of the inclusion of particular cytostatic drugs with activity against T lymphoblasts, e.g. cytarabine and cyclophosphamide
B-cell ALL:
the rate of complete remission has improved from 40% to 70%. The rate of disease-free survival has increased to 70+% in children and 40-50% in adults
improved treatment success is the result of inclusion in chemotherapy of high doses of cyclophosphamide, methotrexate, or cytarabine
Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page